MMS Holdings Expert Insights Blog
Experts at MMS share their insights on trending
topics in the pharmaceutical industry.
Helping to Accelerate the Search for Solutions to the COVID-19 Crisis
The full article can be read on the IBM Watson Health website. An excerpt of the article is below. The novel coronavirus (COVID-19) pandemic is an unprecedented crisis that has galvanized the global scientific community around the search for a viable vaccine and...
IGY Life Sciences Partners with MMS Holdings to Develop Novel COVID-19 Antibody Treatment
THUNDER BAY, ONTARIO (June 09, 2020) — IGY Life Sciences today announced it will be collaborating with clinical data and regulatory experts, MMS Holdings (MMS), to further the development of IgY-110, an anti-CoV-2 therapeutic antibody with a focus on a nasal spray...
University of Michigan School of Information Invites MMS Holdings Executive Kelly J. Hill to Join External Advisory Board
CANTON, Mich. (May 19, 2020) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced today that its Executive Director of Global Business Operations and Strategy Kelly J. Hill has accepted an invitation to join the University of Michigan School of...
On Demand Webinar: Recommended Changes for Pharma Companies in Response to COVID-19
[Fill out the form below to register] In the wake of the COVID-19 pandemic, governments across the globe have rushed to implement countermeasures and develop best practices to curtail the spread of the virus, impacting the conduct of clinical trials in unprecedented...
Green Valley Pharmaceutical And MMS Holdings Collaborate to Gain FDA Approval To Begin Clinical Trial For The First Alzheimer’s Drug In 17 Years
CANTON, Mich. and SHANGHAI (May 5, 2020) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced that a successful collaboration with Shanghai-based Green Valley Pharmaceutical Co. (Green Valley) resulted in gaining U.S. Food & Drug...
With Safety, Urgency, and Innovation: How an Award-Winning CRO Operates During COVID-19
The COVID-19 pandemic has impacted the way many pharmaceutical, biotech, and CRO companies are working, rewarding flexibility and agile resourcing and operating models. In this expert insights blog, we sit down (virtually) with Kelly J. Hill, Executive Director,...
Whitepaper: Six Changes that Pharmaceutical Companies Should Consider in Response to COVID-19
[Fill out the form below to access the whitepaper] In the wake of the global pandemic of COVID-19, also known and SARS-COV-2, regulators, health authorities, and lawmakers across the globe have rushed to implement countermeasures and develop best practices to curtail...
Unprecedented does not have to mean unprepared: Business Continuity Planning
During these unprecedented times, many businesses are struggling to continue business as usual while the world is rapidly changing around them; however, certain businesses continue to thrive. Throughout this COVID-19 pandemic, companies like MMS, among other leaders...
MMS Announces One Million Dollar Award For Pharmaceutical Companies Developing A Vaccine For COVID-19
Canton, Mich. (March 20, 2020) — MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today that it is offering a USD1M award toward the development of a vaccine for COVID-19, also known as the coronavirus. The award is being offered in the form of data...